Veracyte Inc (VCYT NASDAQ) stock market data APIs
$39.2192
-0.87(-2.2%)
as of November 14, 2025
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
39.2192
Open
38.3488
High
39.8511
Low
38.0914
52 wk Range
22.61-47.3162
Market Cap
3 151 M
P/E Ratio
106.3514
Shares Outstanding
79 049 K
Revenue
495 M
EPS
0.51
Beta
1.86
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 495 M
- EBITDA: 74 398 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: 0.3196
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat
Shares of The Ensign Group, Inc. ENSG have fallen 2.2% since it reported third-quarter 2025 results on Nov. 3. Despite an earnings beat, the quarterly results were hurt by an elevated expense level du...
We Think Veracyte's (NASDAQ:VCYT) Robust Earnings Are Conservative
When companies post strong earnings, the stock generally performs well, just like Veracyte, Inc.'s (NASDAQ:VCYT) stock has recently. We did some digging and found some further encouraging factors that...
Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat
Shares of Encompass Health Corporation EHC have fallen 8.3% since it reported third-quarter 2025 results on Oct. 29. The quarterly results were affected by rising operating expense levels due to incre...
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte, Inc. VCYT delivered third-quarter 2025 adjusted earnings of 51 cents per share, which marked a stupendous improvement of 54.5% from the year-ago period’s figure of 33 cents. The bottom lin...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
